Affiliation:
1. Scientific Center for Family Health and Human Reproduction Problems
Abstract
The aim of this work was to study the levels of podocalyxin and β-2-microglobulin and parameters of lipid metabolism and carbonyl stress in type 1 diabetes mellitus (T1DM) patients with different levels of albuminuria.Materials and methods. 56 men of reproductive age with T1DM were divided into two groups: 24 patients with stage A1 albuminuria (group A1) and 32 patients with stage A2 albuminuria (group A2). The control group consisted of 28 healthy men. The levels of renal function markers, lipid metabolism parameters, and methylglyoxal were assessed using enzyme immunoassay and spectrophotometric and fluorometric methods.Results. Higher values for total cholesterol, triacylglycerol, and very-low-density lipoprotein medians in both groups A1 and A2 were found. In these groups, increased podocalyxin and methylglyoxal medians were revealed. Correlation analysis in the group A1 showed the presence of a relationship between the glomerular filtration rate (GFR) and creatinine. In the group A2, correlations between the generally accepted parameters of kidney injury (the albumin / creatinine ratio and GFR) and the duration of the disease and between GFR and the creatinine and methylglyoxal levels in the blood were identified. The podocalyxin level in this group correlated with the β2- microglobulin and methylglyoxal levels and lipid metabolism parameters. The level of β2-microglobulin correlated with the lipid metabolism parameters.Conclusion. Regardless of the level of albuminuria, men with T1DM had significantly increased levels of podocalyxin, lipid metabolism parameters, and methylglyoxal, as well as strong relationships between these parameters. The data of this study can be used for development of potential strategies for prevention and early treatment of diabetic nephropathy.
Publisher
Siberian State Medical University
Reference25 articles.
1. Selby N.M., Taal M.W. An updated overview of diabetic nephropathy: diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism. 2020;22:3–15. DOI: 10.1111/dom.14007.
2. Ryzhikova Yu.A., Vorozhtsova I.N., Saprina T.V., Zavadovskaya V.D., Merinov A.B., Kulagina I.V. Kharakteristika serdechnoi formy belka, svyazyvayushchego zhirnye kisloty, interleikinov-6 i -8 kak al'ternativnykh markerov progressirovaniya diabeticheskoi nefropatii u patsientov s sakharnym diabetom 1-go tipa. Byulleten' sibirskoi meditsiny. 2015;14(5):61–72. DOI: 10.20538/1682-0363-2015-5-61-72.
3. Dedov I.I., Shestakova M.V., Maiorov A.Yu., Shamkhalova M.Sh., Nikonova T.V., Sukhareva O.Yu., Pekareva E.V. i dr. Sakharnyi diabet I tipa u vzroslykh. Sakharnyi diabet. 2020;23(S1):42–112. DOI: 10.14341/DM23S1.
4. Zharikov A.Yu., Shchekochikhina R.O. Diabeticheskaya nefropatiya. Sovremennyi vzglyad na problemu. Byulleten' meditsinskoi nauki. 2018;2(10):24–31.
5. Vodošek Hojs N., Bevc S., Ekart R., Hojs R. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants. 2020;9(10):925. DOI: 10.3390/antiox9100925.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献